Researchers at Moffitt Cancer Center, working with colleagues at The University of Arizona and Arizona State University, have developed a new combination agent approach targeting tumor receptors based on their variety of cell surface proteins. The approach, which was tested in pancreatic cancers and melanoma modeled in tumor-bearing mice, opens the possibility of developing new multivalent agents that can target unique and multiple receptor combinations in tumor cells. This is a significant improvement over current single-target strategies.
Recent PostsTuesday, September 23, 2014
Moffitt Cancer Center and FORMA Therapeutics announced today a bold, collaborative research initiative and exclusive license option agreement focused on histone deacetylases (HDACs) and epigenetics. ..Read More ⇒Tuesday, September 23, 2014
University of Florida researchers are turning to the old-fashioned method of steaming to help treat citrus greening, a disease devastating citrus trees throughout Florida. ..Read More ⇒Tuesday, September 23, 2014
The UCF College of Medicine has received a $500,000 grant from the Florida Legislature to further its research into Crohn’s disease and is sharing the funding with the University of Miami to investigate causes and better treatments for patients sickened with the inflammatory bowel disease. ..Read More ⇒Tuesday, September 23, 2014
The process of turning a creative idea into a marketable innovation is about to get easier, faster and more accessible at the University of Central Florida with the grand opening of four new labs known as Maker Spaces. ..Read More ⇒Monday, September 22, 2014
Scientists from both campuses of The Scripps Research Institute (TSRI) have been awarded a total of $7.9 million from the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. ..Read More ⇒
TagsFlorida Trend Florida Institute of Technology Florida Atlantic University Banyan Biomarkers health biomedical policy agriculture sciences biotechnology nanotechnology Embry-Riddle materials science Nanotheraputics accreditation astronomy BioFlorida partnerships Florida Hospital health care IHMC accolades University of West Florida commercialization FAMU business University of North Florida AxoGen innovation animals Florida State University energy technology University of Central Florida medical Univeristy of South Florida Sanford-Burnham conference / event VGTI Florida Gulf Coast Univ. gender bioscience research awards grants marine aging Florida Power & Light education Enterprise Florida HIV/AIDS Scripps Research Institute AGTC GrowFL Jackson Lab neuroscience photonics magnets society/culture FL Institute for Commercialization of Public Research cancer Torrey Pines Institute ICFO University of Florida accounting University of Miami Nova Southeastern Univ. ecology stem cell engineering Draper aerospace physics Florida International Univ. Max Planck clean energy research policy robotics economy green technology children life science sustainability consumers Moffitt Cancer Center environment computer science